{"nct_id":"NCT01454102","title":"Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2011-12-16","start_date_type":"ACTUAL","primary_completion_date":"2016-07-20","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-23","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}